Ondine Biomedical Past Earnings Performance
Past criteria checks 0/6
Ondine Biomedical has been growing earnings at an average annual rate of 31.4%, while the Medical Equipment industry saw earnings growing at 3.9% annually. Revenues have been growing at an average rate of 103.2% per year.
Key information
31.4%
Earnings growth rate
59.1%
EPS growth rate
| Medical Equipment Industry Growth | -9.5% |
| Revenue growth rate | 103.2% |
| Return on equity | -75,126.3% |
| Net Margin | -873.6% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How Ondine Biomedical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 2 | -14 | 9 | 6 |
| 31 Mar 24 | 1 | -14 | 9 | 6 |
| 31 Dec 23 | 1 | -14 | 10 | 5 |
| 30 Sep 23 | 1 | -17 | 11 | 5 |
| 30 Jun 23 | 1 | -19 | 12 | 6 |
| 31 Mar 23 | 1 | -19 | 12 | 6 |
| 31 Dec 22 | 1 | -19 | 12 | 6 |
| 30 Sep 22 | 1 | -37 | 14 | 6 |
| 30 Jun 22 | 1 | -54 | 16 | 5 |
| 31 Mar 22 | 2 | -52 | 15 | 5 |
| 31 Dec 21 | 3 | -50 | 13 | 5 |
| 31 Dec 20 | 2 | -16 | 12 | 3 |
Quality Earnings: OBI is currently unprofitable.
Growing Profit Margin: OBI is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OBI is unprofitable, but has reduced losses over the past 5 years at a rate of 31.4% per year.
Accelerating Growth: Unable to compare OBI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OBI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (39.9%).
Return on Equity
High ROE: OBI has a negative Return on Equity (-75126.32%), as it is currently unprofitable.